RecruitingNCT07022704
Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial
The Influence of Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial: a Prospective Observational Study
Sponsor
Cairo University
Enrollment
35 participants
Start Date
Jun 22, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Researchers aim to evaluate the impact of doxapram administration on diaphragmatic excursion in chronic obstructive pulmonary disease (COPD) patients undergoing spontaneous breathing trial
Eligibility
Min Age: 20 YearsMax Age: 65 Years
Inclusion Criteria1
- Patients with moderate to severe chronic obstructive pulmonary disease undergoing spontaneous breathing trial
Exclusion Criteria1
- Refusal Allergy to doxapram neuromuscular disorders inability to evaluate the diaphragm
Interventions
DRUGDoxapram
Doxapram will be given as 1.5 mg/kg will be given 10 minutes after the initiation of SBT
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07022704
Related Trials
Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
NCT0724557612 locations
Home Hospital for Suddenly Ill Adults
NCT035242222 locations
A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
NCT070863392 locations
The ED-AWARENESS-2 Trial
NCT055342434 locations
Effect of Telenursing on Oral Health
NCT074622211 location